Anti-Cancer Drugs to Become More Affordable
The National Pharmaceutical Pricing Authority (NPPA) has directed manufacturers to reduce the Maximum Retail Price (MRP) of Trastuzumab, Osimertinib, and Durvalumab. This reduction in MRP is a result of the government’s initiative to exempt these drugs from customs duty and reduce GST rates.
India Unveils National Strategy to Combat Unintentional Injuries
The Indian government has released a National Strategy for the Prevention of Unintentional Injuries. This framework aims to address the pressing issue of unintentional injuries, which pose a significant public health burden in the country.
